As previously announced, the 4th World Congress on Tuberculosis will be held in Washington, DC, on June 3-5. Co-sponsored by NIH, WHO (TDR and Stop TB), KNCV, CDC, and a number of other organizations, the Congress will evaluate the state of the global tuberculosis epidemic since the last TB World Congress held in 1992, review the status of TB research and identify research gaps. Topics covered will include fundamental, translational and operational research. Attendance should be of interest to global TB control officials, TB researchers, health systems services researchers, policymakers and funders, as well as infectious disease and pulmonary physicians.

The Program Committee invites the submission of abstracts for inclusion in the poster sessions. The committee will review all submitted awards. A small number of abstracts may be selected for "late breaker" oral presentations.

Abstracts are due by March 1, and notification of acceptance will be sent out on or about April 1. For international travelers only, a limited amount of travel support may be available for those presenting posters or "late breaker" talks.

Detailed information about the meeting program and abstract submission can be found on the meeting website (http://www.niaid.nih.gov/dmid/tuberculosis/tbcongress/).